Microbiotica is working on microbiome therapies in Cambridge, UK, with lead programs in immuno-oncology and inflammatory bowel disease
CEO Tim Sharpington describes the advances that have been made in the microbiome field over the last decade and introduces us to Microbiotica's programs.